These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 21720253

  • 1. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
    Zhou L, Cai B, Bao W, He YY, Chen XY, Yang YX, Liu XL, Wan XP.
    Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
    [Abstract] [Full Text] [Related]

  • 2. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
    Lu Y, Jiang S, Zhang J, Song H, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):925-31. PubMed ID: 25608994
    [Abstract] [Full Text] [Related]

  • 3. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z, Qi S, Zhao X, Li M, Ding S, Lu J, Zhang H.
    Oncotarget; 2016 Apr 19; 7(16):21315-31. PubMed ID: 26824324
    [Abstract] [Full Text] [Related]

  • 4. BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway.
    Wang F, Chen Q, Huang G, Guo X, Li N, Li Y, Li B.
    BMC Cancer; 2018 Nov 16; 18(1):1128. PubMed ID: 30445932
    [Abstract] [Full Text] [Related]

  • 5. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
    Zhang SQ, Cai B, Liu L, He YY, Yang YX, Wan XP.
    Int J Gynecol Cancer; 2009 Nov 16; 19(8):1377-83. PubMed ID: 20009893
    [Abstract] [Full Text] [Related]

  • 6. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar 16; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 7. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.
    Zheng A, Kallio A, Härkönen P.
    Endocrinology; 2007 Jun 16; 148(6):2764-77. PubMed ID: 17363451
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T, Gomes A.
    Chem Biol Interact; 2017 Apr 25; 268():119-128. PubMed ID: 28322778
    [Abstract] [Full Text] [Related]

  • 9. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway.
    He YY, Cai B, Yang YX, Liu XL, Wan XP.
    Cancer Sci; 2009 Jun 25; 100(6):1051-61. PubMed ID: 19432902
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 11. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].
    Jiang XL, Gao JC, Jiang L, Zhang PX, Kang TJ, Sun Q, Qi WJ, Zhang QP, Guan HW, Shi H.
    Zhonghua Fu Chan Ke Za Zhi; 2019 Aug 25; 54(8):541-547. PubMed ID: 31461811
    [Abstract] [Full Text] [Related]

  • 12. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y.
    Oncol Rep; 2012 Feb 25; 27(2):504-10. PubMed ID: 22075757
    [Abstract] [Full Text] [Related]

  • 13. SRC kinase and mitogen-activated protein kinases in the progression from normal to malignant endometrium.
    Desouki MM, Rowan BG.
    Clin Cancer Res; 2004 Jan 15; 10(2):546-55. PubMed ID: 14760076
    [Abstract] [Full Text] [Related]

  • 14. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
    Wang Y, Gao C, Zhang Y, Gao J, Teng F, Tian W, Yang W, Yan Y, Xue F.
    Gynecol Oncol; 2016 Oct 22; 143(1):168-178. PubMed ID: 27473926
    [Abstract] [Full Text] [Related]

  • 18. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
    Kashima H, Shiozawa T, Miyamoto T, Suzuki A, Uchikawa J, Kurai M, Konishi I.
    Endocr Relat Cancer; 2009 Mar 22; 16(1):113-22. PubMed ID: 18852162
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.